HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $801,000 | -5.9% | 20,278 | -3.4% | 0.03% | -11.4% |
| Q1 2017 | $851,000 | -5.2% | 20,985 | -6.0% | 0.04% | -14.6% |
| Q4 2016 | $898,000 | +7.9% | 22,326 | -2.8% | 0.04% | +2.5% |
| Q3 2016 | $832,000 | +232.8% | 22,958 | +279.8% | 0.04% | +166.7% |
| Q2 2015 | $250,000 | -9.7% | 6,045 | -2.1% | 0.02% | -6.2% |
| Q1 2015 | $277,000 | +24.8% | 6,176 | +4.3% | 0.02% | +14.3% |
| Q4 2014 | $222,000 | +5.2% | 5,924 | -2.1% | 0.01% | 0.0% |
| Q3 2014 | $211,000 | +1.0% | 6,049 | +2.0% | 0.01% | 0.0% |
| Q2 2014 | $209,000 | +13.0% | 5,931 | +4.6% | 0.01% | +7.7% |
| Q1 2014 | $185,000 | -17.8% | 5,672 | +6.3% | 0.01% | -27.8% |
| Q4 2013 | $225,000 | +14.2% | 5,338 | +8.2% | 0.02% | 0.0% |
| Q3 2013 | $197,000 | +24.7% | 4,935 | +28.8% | 0.02% | +5.9% |
| Q2 2013 | $158,000 | – | 3,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |